The Hollfelder Group have published a new paper in the journal Chemistry & Biology.
A collaboration between Florian Hollfelder's group and MedImmune, the global biologics research and development arm of AstraZeneca, has led the researchers to identify a potentially significant new application for a well-known human enzyme, which may have implications for treating respiratory diseases such as asthma. Read the full story on the University website.